Advertisement

Topics

Latest Cancer NewsRSS

22:16 EDT 19th September 2017 | BioPortfolio

Arcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical Co. Ltd.

Arcus Biosciences, a US-based biotechnology company focused on the discovery and development of innovative cancer immunotherapies, announced today that it has entered into an option and license agreement with Taiho Pharmaceutical Co. Ltd., for the potential development and commercialization of product candidates in Arcus’s portfolio in Japan and certain ...

Rexahn Pharmaceuticals Inc RNN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryRexahn Pharmaceuticals Inc Rexahn Pharmaceuticals, formerly Corporate Road Show.com Inc is a clinical stage biopharmaceutical company that offers discovery, development and commercialization of therapeutics for the treatment of cancer. The company develops anticancer drug candidates which include Archexin that is intended for the treatment of pancreatic cancer. It develops RX3117 used for t...

DiaSorin: Market Shares and Competitive Position by Product and CountryPerformance, Capabilities, Goals and Strategies in the Global Diagnostics Industry [Report Updated: 24082017] Prices from USD $6500

This unique market intelligence report from LeadingMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product and country for DiaSorin and its main competitors, as well as a profile of the companyrsquo;s diagnostics business. List of Tables Clinical Chemistry and Immunodiagnostics Market DiaSorin Ge...

Oregon Health Science University Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummaryOregon Health Science University OHSU, a subsidiary of Oregon State University is an academic health center that provides medical education, research, patient care and community services. The center's educational institute offers undergraduate and graduate courses in anesthesiology, dermatology, neurology, psychiatry, periodontology and nursing. It grants doctoral degrees in medicine, dent...

Global Circulating Tumor Cells Market Data Survey Report 2025 [Report Updated: 11082017] Prices from USD $1500

SummaryThis report mainly covers Circulating Tumor Cells products, by types CTC enrichment, CTC detection and CTC analysis, by applications Prostate Cancer, Breast Cancer, Colorectal Cancer Diagnosis and Treatment and Others.The global Circulating Tumor Cells market will reach Volume Million USD in 2017 with CAGR xx% 20182025. The main contents of the report including:Global market size and foreca...

#jobs #lifescience PhD Position – Epigenetic Characterization of Cancer Associated Fibroblasts

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: PhD Position – Epigenetic Characterization of Cancer Associated Fibroblasts .The group Stem Cell Biology and Cellular Engineering at the Helmholtz-Institute for Biomedical Engineering is offering a position for … Continue reading → Cet article #jobs #lifescie...

Dr. Nicholas Bernthal of UCLA/Orthopaedic Institute for Children Named 2017 Leonard Tow Humanism in Medicine Award Recipient

Nicholas Bernthal, M.D., assistant professor-in-residence at the UCLA/Orthopaedic Institute for Children’s Department of Orthopaedics, has been awarded the 2017 Leonard Tow Humanism in Medicine Award by the David Geffen School of Medicine at UCLA. This award recognizes faculty members and graduating students who demonstrate both clinical excellence and o...

H. Lee Moffitt Cancer Center Research Institute Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryH Lee Moffitt Cancer Center Research Institute Inc Moffitt is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such as surgical care, fertility preservation, radiation therapy, interventional radiology, rehabilitation s...

Exelixis to Present at the Cantor Fitzgerald Healthcare Conference on September 25

-- Presentation to be webcast on www.exelixis.com -- Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will provide an overview of the company at the Cantor Fitzgerald Healthcare Conference taking place September 25-27 in New York, NY. The Exelixis presentation i...

Therapure Biopharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryTherapure Biopharma Inc Therapure is a biopharmaceutical company that offers research and development services. The company's activities include manufacture, development, purification, and packaging of therapeutic proteins and followon biologics. It operates through its division therapure biomanufacturing, therapure innovations and therapure biologics. Therapure's therapure biomanufacturing...

Pain Therapeutics Drugs, Markets and Companies [Report Updated: 08092017] Prices from USD $4000

SummaryThis report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic pain and cancer pain. Because pain is a subjective sensation, it is difficult to evaluate objectively in clinical trials. Various tools for pain measurement are described, including brai...

Global Epigenetics Market 20172021 [Report Updated: 14082017] Prices from USD $3500

About EpigeneticsEpigenetics is a biological process to control gene expression by altering the chromatin structure. Genes which are going to be expressed are associated with accessible chromatin regions, whereas silent genes are often associated with inaccessible chromatin regions. Epigenetics products that include reagents, kits, enzymes, instruments, and drugs help in analyzing epigenetic chang...

Lymphoma Research Foundation Returns to Texas to Host Swirl: A Wine Tasting Event

National Fundraising Series Comes to Dallas at 3015 at Trinity Groves to Benefit Nation’s Largest Lymphoma-Specific Nonprofit Organization Dallas, TX (PRWEB) September 19, 2017 The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of e...

RAC Gamma Serine/Threonine Protein Kinase Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1 Pipeline Review, H2 2017 [Report Updated: 29082017] Prices from USD $3500

RAC Gamma Serine/Threonine Protein Kinase Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1 Pipeline Review, H2 2017SummaryRAC Gamma Serine/Threonine Protein Kinase Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1 RACgamma serine/threonineprotein kinase is an enzyme encoded by the AKT3 gene. AKT3 regulate ...

Pfizer Announces Outcome of FDA Advisory Committee Meeting for SUTENT® in Patients at High Risk of Recurrent Renal Cell Carcinoma after Surgery

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drug Advisory Committee (ODAC) voted 6 in favor and 6 against the benefit-risk profile for SUTENT® (sunitinib) as adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma (RCC) after nephrectomy (surgical removal of the cancer-c...

VolitionRx Announces its European Colorectal Cancer Strategy

ISNES, Belgium, Sept. 19, 2017 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced its colorectal cancer (CRC) strategy for Europe.  As part of its strategy, Volition plans to select a frontline panel to be validated in two large trials (4,300 and 10,000 sample), followed by CE marking, with a goal to launch a European frontline CRC screening product in ...

Mirati Therapeutics To Present At Upcoming Healthcare Conferences

SAN DIEGO, Sept. 19, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology biotechnology company, will present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York on Tuesday, September 26th at 1:40 p.m. ET/ 10:40 a.m. PT. Mirati will also participate in the Leerink Partners Roundtable Series – Rare Disease & Immuno-Oncology ...

Brides Against Breast Cancer® Donating 200 FREE Designer Wedding Dresses to Brides in Need – Seeking Applicants! Bringing Awareness of October Breast Cancer Month

While supplies last, a bride can select a dress on our web store, share her story why she needs it for free, and simply pay the shipping and handling! Brides Against Breast Cancer® (“BABC”) is giving away 200 designer wedding dresses (originally retailing up to $2,000) to brides in need. The bride picks the dress from our web store, shares her ...

Siris Medical Inc. Raises $4 Million to Improve Cancer Radiation Treatment With Artificial Intelligence

DigiTx Partners Leads Series A1 Round with Participation from Medical Technology Venture Partners Siris Medical, a Redwood City-based company which has commercialized the first artificial intelligence treatment decision support system in radiation therapy, announced today it has raised $4.0 million in Series A1 financing. The proceeds will be used to e...

Ipsen Receives Approval from European Commission for Xermelo® (Telotristat Ethyl) for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy

For patients living with neuroendocrine tumors, insufficiently controlled carcinoid syndrome can be a major burden that severely impacts quality of life1 Xermelo® (telotristat ethyl) 250mg demonstrates sustained improvement of carcinoid syndrome diarrhea when associated with somatostatin analogues (SSA) ...

Transgene: First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers

Clinical Trial in Collaboration with the Alliance between Merck KGaA, Darmstadt, Germany, and Pfizer First Results Expected in 2018 Transgene (Paris:TNG), a biotech company that designs and develops viral-based immunotherapies, today announces that the first patient has been treated at the Curie Institute, Paris, France, in a Phase 1b/2 ...

University Health Network Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28082017] Prices from USD $250

SummaryUniversity Health Network UHN is a health care institution that provides patient care, research and educational services, and patient support services. It offers health care services such as palliative care, pharmacy and telehealth. UHN also provides specialized program services, accessibility, health records, hospitality services and volunteer resources. The organization conducts research ...

Leiomyosarcoma Pipeline Review, H2 2017 [Report Updated: 22082017] Prices from USD $2000

Leiomyosarcoma Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leiomyosarcoma Pipeline Review, H2 2017, provides an overview of the Leiomyosarcoma Oncology pipeline landscape.Leiomyosarcoma is an aggressive soft tissue sarcoma derived from smooth muscle cells typically of uterine, gastrointestinal or soft tissue origin. Symptoms ...

National Association of Specialty Pharmacy Names Ardon Health Specialty Pharmacy of the Year & Honors Mike Agostino with the Distinguished Service Award

WASHINGTON, Sept. 19, 2017 /PRNewswire-USNewswire/ -- Kicking off the fifth annual National Association of Specialty Pharmacy (NASP) meeting today, outgoing NASP President Rebecca Shanahan announced the industry's two much-anticipated awards recognizing the best in the business of specialty pharmacy this year. Of the 1,200 corporate association members, Ardon Health was named Specialty P...

AEG Partners With Nautica Malibu Triathlon to Raise More Than $24,000 for Children’s Hospital Los Angeles

AEG employees compete for second year in triathlon’s Entertainment Industry Challenge SOURCE: AEG DESCRIPTION:AEG, the leading sports and live entertainment company in the world, partnered with Nautica Malibu Triathlon for the second consecutive year to raise more than $24,000 for Children’s Hospital Los Angeles (CHLA) in conjunction with the 31st annual Nautica Malibu Triathlon presented by E...

Quick Search
Advertisement
 

review and buy Cancer market research data and corporate reports here